UTHR
United Therapeutics Corporation
Drug Manufacturers - Specialty & Generic · Healthcare · United States
501.27
close · 2026-08-13
value
31
cheaper than peers31
quality
76
stronger fundamentals76
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 3.34× | 57 |
| EV to EBITDA | 13.67× | 48 |
| forward P/E | 16.61× | 35 |
| price to sales | 7.20× | 11 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 42.2% | 93 |
| return on equity | 19.3% | 73 |
| revenue growth | -1.9% | 23 |
3 of 4 measures available
Facts
| market cap | $21B |
| free cash flow | $557.1M |
| employees | 1,400 |
| first trade | 1999-06-17 |
| next earnings | 2026-08-05 |
| fundamentals updated | 2026-08-10 |